Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Ling, Charlotte ^a   Groop, Leif ^a   Del Guerra, Silvia ^b   Lupi, Roberto ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALPAIN 10; GLIBENCLAMIDE; GLUCOSE; MESSENGER RNA; CALPAIN; INSULIN; PRIMER DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; PANCREAS ISLET; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PANCREAS TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION;

RODENTIA;

ARGININE; BASE SEQUENCE; CALPAIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; GLUCOSE; GLYBURIDE; HUMANS; INSULIN; ISLETS OF LANGERHANS; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 68949213757     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006558     Document Type: Article

References (22)

1. Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8: 657-662.
2. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163-175.
3. Tsuchiya T, Schwarz PE, Bosque-Plata LD, Geoffrey Hayes M, Dina C, et al. (2006) Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab 89: 174-184.
4. Cox NJ, Hayes MG, Roe CA, Tsuchiya T, Bell GI (2004) Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes 53 Suppl 1: S19-25.
5. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, et al. (2002) Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51: 3561-3567.
6. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, et al. (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69: 544-552.
7. Croall DE, DeMartino GN (1991) Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev 71: 813-847.
8. Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KP, et al. (2001) Calpains play a role in insulin secretion and action. Diabetes 50: 2013-2020.
9. Carlsson E, Poulsen P, Storgaard H, Almgren P, Ling C, et al. (2005) Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle. Diabetes 54: 3015-3020.
10. Orho-Melander M, Klannemark M, Svensson MK, Ridderstrale M, Lindgren CM, et al. (2002) Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51: 2658-2664.
11. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, et al. (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106: R69-73.
12. Zhou YP, Sreenan S, Pan CY, Currie KP, Bindokas VP, et al. (2003) A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 52: 528-534.
13. Parnaud G, Hammar E, Rouiller DG, Bosco D (2005) Inhibition of calpain blocks pancreatic beta-cell spreading and insulin secretion. Am J Physiol Endocrinol Metab 289: E313-321.
14. Marshall C, Hitman GA, Partridge CJ, Clark A, Ma H, et al. (2005) Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol Endocrinol 19: 213-224.
15. Tripathy D, Eriksson KF, Orho-Melander M, Fredriksson J, Ahlqvist G, et al. (2004) Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes. Diabetologia 47: 782-793.
16. Johnson JD, Han Z, Otani K, Ye H, Zhang Y, et al. (2004) RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets. J Biol Chem 279: 24794-24802.
17. Carlsson E, Fredriksson J, Groop L, Ridderstrale M (2004) Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J Clin Endocrinol Metab 89: 3601-3605.
18. Ling C, Del Guerra S, Lupi R, Ronn T, Granhall C, et al. (2008) Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia.
19. Del Guerra S, Lupi R, Marselli L, Masini M, Bugliani M, et al. (2005) Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 54: 727-735.
20. Marchetti P, Bugliani M, Lupi R, Marselli L, Masini M, et al. (2007) The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50: 2486-2494.
21. Turner MD, Fulcher FK, Jones CV, Smith BT, Aganna E, et al. (2007) Calpain facilitates actin reorganization during glucose-stimulated insulin secretion. Biochem Biophys Res Commun 352: 650-655.
22. Stumvoll M, Fritsche A, Madaus A, Stefan N, Weisser M, et al. (2001) Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes 50: 2161-2163.